Here are the 424B prospectus supplements from INLIF Limited (INLF) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow INLF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INLF filings page.
INLIF Limited (INLF) is offering up to 435,000 Class A ordinary shares at $1.60 each with Series A, B and C warrants, on a best-efforts basis. It also offers pre-funded warrants in lieu of shares under ownership limits; up to 28,976,772 Class A shares underlying the warrants are registered. Assuming all pre-funded warrants are exercised, the approximate total offering price is $3,750,000, with $3,487,500 in proceeds to INLIF before expenses and $262,500 in placement-agent fees. Closing is expected on or about October 20, 2026, subject to customary conditions.
Proceeds are intended for directors’ and officers’ insurance and working capital, including a Phase II manufacturing facility, production and R&D equipment, the Xiamen headquarters and R&D platform, new-product development and recruitment; deployment is expected over one to two years. For the six months ended June 30, 2026, revenue was $12,942,657 and net income was $1,009,010, versus $10,270,988 in revenue and a $1,975,420 net loss in the comparable 2025 period.
INLIF is a Cayman Islands holding company whose operations are conducted substantially through a PRC operating entity; investors receive holding-company securities, not direct equity in that entity. The company cites PRC regulatory and cross-border cash-transfer risks and says no active market is expected for the warrants. Series A warrants expire five years after issuance; Series B warrants expire after 60 days.
INLIF Limited has registered up to $100,000,000 of Class A Ordinary Shares for sale in an at-the-market offering under a Sales Agreement with AC Sunshine Securities LLC.
The Sales Agent may sell shares from time to time as an agent or principal at market prices and will receive a fixed commission of 3.0% of gross proceeds. The prospectus supplement states the company had 208,400,000 Class A Ordinary Shares and 12,500,000 Class B Ordinary Shares outstanding as of the date of the supplement, and that the company completed a PIPE on February 10, 2026 issuing 202,000,000 Class A shares for gross proceeds of $32,344,240.00. The prospectus supplement discloses Nasdaq bid-price noncompliance and a compliance period through April 27, 2026. The offering proceeds are designated for general corporate purposes.